 |
|
Acute kidney injury aggravated by treatment initiation with apixaban: Another twist of anticoagulant-related nephropathy
Sergey V. Brodsky, Nilesh S. Mhaskar, Sampath Thiruveedi, Rajnish Dhingra, Sharon C. Reuben, Edward Calomeni, Iouri Ivanov, Anjali Satoskar, Jessica Hemminger, Gyongyi Nadasdy, Lee Hebert, Brad Rovin, Tibor Nadasdy
Kidney Res Clin Pract. 2017;36(4):387-392. Published online 2017 Dec 31 DOI: https://doi.org/10.23876/j.krcp.2017.36.4.387
|
|
Citations to this article as recorded by
 Associations of acute kidney injury with oral anticoagulants: a disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database
Hehe Bai, Jinping Wang, Xiaojing Nie, Huan Li, Li Ma, Xiaonian Han, Lirong Peng
Expert Opinion on Drug Safety.2025; : 1. CrossRef Edoxaban-induced acute interstitial nephritis
Shiko Gen, Ririko Higashi, Natsuki Nagae, Ryuta Kigure, Yuta Kamikubo, Kanako Nobe, Naofumi Ikeda
CEN Case Reports.2025;[Epub] CrossRef Risk of acute renal failure associated with combined use of SGLT2 inhibitors and potentially nephrotoxic drugs: an epidemiological surveillance study based on the FDA adverse event reporting system (FAERS)
Ting Yu, Jian Xiao, Mengyao Li, Shu Qiao Cheng, Ruwen Cai, Ling Huang, Huimin Yu, Jing Yang Li, Ying-Ying Zhang, Ying Wang
Expert Opinion on Drug Safety.2025; : 1. CrossRef Kidney Toxicity of Drugs for the Heart: An Updated Perspective
Carlo Caiati, Roberto Arrigoni, Alessandro Stanca, Mario Erminio Lepera
Metabolites.2025; 15(3): 191. CrossRef Oral anticoagulant treatment and risk of kidney disease—a nationwide, population-based cohort study
Ane Emilie Friis Vestergaard, Simon Kok Jensen, Uffe Heide-Jørgensen, Kasper Adelborg, Henrik Birn, Juan-Jesus Carrero, Christian Fynbo Christiansen
Clinical Kidney Journal.2024;[Epub] CrossRef Acute Kidney Injury in Different Anticoagulation Strategies: A Large-Scale Pharmacoepidemiologic Study Using Real-World Data
Qiuyu Xu, Gang Chen, Sanxi Ai, Ke Zheng, Bin Zhao, Xuemei Li
Cardiovascular Drugs and Therapy.2024;[Epub] CrossRef Correlation of Red Blood Cell Casts With Renal Dysfunction in Patients With Infection-Related Glomerulonephritis
Mineaki Kitamura, Laura Biederman, Dalia Ibrahim, Tibor Nadasdy, Sergey V. Brodsky, Anjali A. Satoskar
Archives of Pathology & Laboratory Medicine.2024; 148(5): 545. CrossRef An Overlap of Anticoagulant-Related and IgA Nephropathy: A Case Report
Mercedes Galloway, John J. Sim, Andrew Slater, Christopher Bray, Daniel Bishev, Patrick Walker
Glomerular Diseases.2024; 4(1): 167. CrossRef Respuesta a la carta al director referida a «Fibrilación auricular no valvular en pacientes en hemodiálisis crónica. ¿Debemos anticoagular?»
Carmen Sánchez-Gonzalez, José A. Herrero Calvo
Nefrología.2023; 43(1): 150. CrossRef Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants
Marco Trevisan, Paul Hjemdahl, Catherine M. Clase, Ype de Jong, Marie Evans, Rino Bellocco, Edouard L. Fu, Juan Jesus Carrero
American Journal of Kidney Diseases.2023; 81(3): 307. CrossRef Anticoagulant-related nephropathy induced by direct-acting oral anticoagulants: Clinical characteristics, treatments and outcomes
Shanshan Chen, Dehua Liao, Minghua Yang, Shengfeng Wang
Thrombosis Research.2023; 222: 20. CrossRef Reply to the letter to the editor regarding “Nonvalvular atrial fibrillation in patients undergoing chronic haemodialysis, should we anticoagulate?”
Carmen Sánchez-Gonzalez, Jose A. Herrero Calvo
Nefrología (English Edition).2023; 43(1): 150. CrossRef The Crosstalk between Nephropathy and Coagulation Disorder: Pathogenesis, Treatment, and Dilemmas
Zhiwei Qiu, Xiaocong Pang, Qian Xiang, Yimin Cui
Journal of the American Society of Nephrology.2023; 34(11): 1793. CrossRef An Inconspicuous Offender: Apixaban-Induced Anticoagulant-Related Nephropathy
Dylan J Shaw, Stephanie Kaiser, Alexander Kong, Shivam Joshi
Cureus.2023;[Epub] CrossRef The impact of anticoagulation therapy on kidney function in patients with atrial fibrillation and chronic kidney disease
Jelena Simic, Miroslav Mihajlovic, Nevena Zec, Vladan Kovacevic, Milan Marinkovic, Nebojsa Mujovic, Tatjana Potpara
Expert Review of Cardiovascular Therapy.2023; 21(12): 937. CrossRef IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy
Hernando Trujillo, Justo Sandino, Teresa Cavero, Fernando Caravaca-Fontán, Eduardo Gutiérrez, Ángel M. Sevillano, Amir Shabaka, Gema Fernández-Juárez, Pablo Rodríguez Doyágüez, Rocío Gimena Muñoz, Leonardo Calle García, Virginia Cabello, José Manuel Muñoz
Kidney International Reports.2022; 7(4): 831. CrossRef Simultaneous subacute interstitial nephritis and anticoagulant-related nephropathy related to novel oral anticoagulants use
Zhen-Ling Deng, Wen-Ling Yang, Xin-Yue Zhao, Zi-Yong Tang, Dan-Xia Zheng, Yue Wang
Renal Failure.2022; 44(1): 30. CrossRef Fibrilación auricular no valvular en pacientes en hemodiálisis crónica. ¿Debemos anticoagular?
Carmen Sánchez-González, Jose Antonio Herrero Calvo
Nefrología.2022; 42(6): 632. CrossRef Use of the Capture-Recapture Method to Estimate the Frequency of Community- and Hospital-Acquired Drug-Induced Acute Kidney Injuries in French Databases
Amayelle Rey, Valérie Gras, Julien Moragny, Gabriel Choukroun, Kamel Masmoudi, Sophie Liabeuf
Frontiers in Pharmacology.2022;[Epub] CrossRef Role of protease‐activated receptor‐1 (PAR‐1) in the glomerular filtration barrier integrity
Ajay Medipally, Min Xiao, Laura Biederman, Anjali A. Satoskar, Iouri Ivanov, Brad Rovin, Samir Parikh, Bryce A. Kerlin, Sergey V. Brodsky
Physiological Reports.2022;[Epub] CrossRef Challenging clinical scenarios for therapeutic anticoagulation: A practical approach
Kylee L. Martens, Simone E. Dekker, Megan Crowe, Thomas G. DeLoughery, Joseph J. Shatzel
Thrombosis Research.2022; 218: 72. CrossRef Nonvalvular atrial fibrillation in patients undergoing chronic hemodialysis. Should dialysis patients with atrial fibrillation receive oral anticoagulation?
Carmen Sánchez-González, Jose Antonio Herrero Calvo
Nefrología (English Edition).2022; 42(6): 633. CrossRef Anticoagulación oral en la enfermedad renal crónica con fibrilación auricular
Pablo Gómez-Fernández, Antonio Martín Santana, Juan de Dios Arjona Barrionuevo
Nefrología.2021; 41(2): 137. CrossRef Use of Non-vitamin K Antagonist Oral Anticoagulants for Stroke Prevention across the Stroke Spectrum: Progress and Prospects
A. John Camm, Dan Atar
Thrombosis and Haemostasis.2021; 121(06): 716. CrossRef Acute kidney injury pathology and pathophysiology: a retrospective review
Joseph P Gaut, Helen Liapis
Clinical Kidney Journal.2021; 14(2): 526. CrossRef CKD Progression in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation Treated With Apixaban Versus Warfarin
James B. Wetmore, Heng Yan, Charles A. Herzog, Eric Weinhandl, Jorge L. Reyes, Nicholas S. Roetker
American Journal of Kidney Diseases.2021; 78(2): 180. CrossRef Role of glomerular filtration rate‐modifying drugs in the development of anticoagulant‐related nephropathy
Ajay K. Medipally, Min Xiao, Brad H. Rovin, Anjali A. Satoskar, Iouri Ivanov, Shahzeb Qaisar, Sergey V. Brodsky
Physiological Reports.2021;[Epub] CrossRef Management of Anticoagulant-Related Nephropathy: A Single Center Experience
Tanja Belčič Mikič, Nika Kojc, Maja Frelih, Andreja Aleš-Rigler, Željka Večerić-Haler
Journal of Clinical Medicine.2021; 10(4): 796. CrossRef Non‐Vitamin K Antagonist Oral Anticoagulants Provide Less Adverse Renal Outcomes Than Warfarin In Non‐Valvular Atrial Fibrillation: A Systematic Review and MetaAnalysis
Patita Sitticharoenchai, Kullaya Takkavatakarn, Smonporn Boonyaratavej, Kearkiat Praditpornsilpa, Somchai Eiam‐Ong, Paweena Susantitaphong
Journal of the American Heart Association.2021;[Epub] CrossRef Oral anticoagulation in chronic kidney disease with atrial fibrillation
Pablo Gomez -Fernández, Antonio Martín Santana, Juan de Dios Arjona Barrionuevo
Nefrología (English Edition).2021; 41(2): 137. CrossRef The change of renal functions after nonvitamin K oral anticoagulants in patients with atrial fibrillation
Thoranis Chantrarat, Sakolrat Hauythan
IJC Heart & Vasculature.2021; 35: 100844. CrossRef The Risk of Acute Kidney Injury with Oral Anticoagulants in Elderly Adults with Atrial Fibrillation
Ziv Harel, Eric McArthur, Nivethika Jeyakumar, Manish M. Sood, Amit X. Garg, Samuel A. Silver, Paul Dorian, Daniel Blum, William Beaubien-Souligny, Andrew T. Yan, Sunil V. Badve, Brendan Smyth, Min Jun, Racquel Jandoc, Abhijat Kitchlu, Ron Wald
Clinical Journal of the American Society of Nephrology.2021; 16(10): 1470. CrossRef The impact on renal function after long-term use of anticoagulants in atrial fibrillation patients
Wei-Chieh Lee, Pai-Wei Lee, Po-Jui Wu, Yen-Nan Fang, Huang-Chung Chen, Yu-Sheng Lin, Hsiu-Yu Fang, Shang-Hung Chang, Ping-Yen Liu, Mien-Cheng Chen
Thrombosis Journal.2021;[Epub] CrossRef A Case of Anticoagulant Related Nephropathy Caused by Dabigatran with a Clinical Presentation of Pulmonary Renal Syndrome
Tadashi Eguchi, Seiji Takenouchi, Naofumi Higuchi, Tomo Suzuki, Kanako Nagaoka, Keishin Sunagawa, Makito Yaegashi
Nihon Naika Gakkai Zasshi.2021; 110(5): 981. CrossRef Drug-Induced Glomerulonephritis
Frank B. Cortazar, Reza Zonozi
Nephrology Self-Assessment Program.2020; 19(2): 156. CrossRef Hematuria Is Associated with More Severe Acute Tubulointerstitial Nephritis
Raquel Esteras, Jonathan G. Fox, Colin C. Geddes, Bruce Mackinnon, Alberto Ortiz, Juan Antonio Moreno
Journal of Clinical Medicine.2020; 9(7): 2135. CrossRef Dabigatran-induced anticoagulant-related nephropathy with undiagnosed IgA nephropathy in a patient with normal baseline renal function
Masaki Ikeda, Mari Tanaka, Saeko Shimoda, Hirona Saita, Seira Nishikawa, Hiroki Shimada, Keisuke Taniguchi, Koichiro Hagihara, Sachio Iwanari, Hiroya Takeoka
CEN Case Reports.2019; 8(4): 292. CrossRef Rivaroxaban-related acute kidney injury in a patient with IgA vasculitis
Yoshihiko Fujino, Chisato Takahashi, Kensuke Mitsumoto, Takashi Uzu
BMJ Case Reports.2019; 12(1): e227756. CrossRef Anticoagulation-Related Nephropathy: The Most Common Diagnosis You've Never Heard Of
Thomas Oliver, Liann Abu Salman, Brandon Ciaudelli, David A. Cohen
The American Journal of Medicine.2019; 132(8): e631. CrossRef Republished: Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis
Christina DiMaria, Wael Hanna, Julie Murone, James Reichart
Drug and Therapeutics Bulletin.2019; 57(11): 173. CrossRef Investigation on Dabigatran Etexilate and Worsening of Renal Function in Patients with Atrial fibrillation: The IDEA Study
Mauro Molteni, Matteo Crippa, Annalisa Orenti, Hernan Polo Friz, Anna Menghini, Pierluigi Tramacere, Giuseppe Marano, Claudio Cimminiello, Patrizia Boracchi
Clinical Drug Investigation.2019; 39(4): 355. CrossRef Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis
Christina DiMaria, Wael Hanna, Julie Murone, James Reichart
BMJ Case Reports.2019; 12(6): e230371. CrossRef Dabigatran Toxicity in Acute Kidney Injury: Hemodialysis and Idarucizumab Required
Lucy McBride, Julie Wang, Prahlad Ho, David Langsford
Kidney International Reports.2019; 4(3): 500. CrossRef Glomerular Hematuria: Cause or Consequence of Renal Inflammation?
Juan Antonio Moreno, Ángel Sevillano, Eduardo Gutiérrez, Melania Guerrero-Hue, Cristina Vázquez-Carballo, Claudia Yuste, Carmen Herencia, Cristina García-Caballero, Manuel Praga, Jesús Egido
International Journal of Molecular Sciences.2019; 20(9): 2205. CrossRef Anticoagulant-related nephropathy: a pathological note
Vincenzo L’Imperio, Alessia Guarnieri, Federico Pieruzzi, Renato Alberto Sinico, Fabio Pagni
Journal of Thrombosis and Thrombolysis.2018; 46(2): 260. CrossRef Anticoagulant-Related Nephropathy
Sergey Brodsky, John Eikelboom, Lee A. Hebert
Journal of the American Society of Nephrology.2018; 29(12): 2787. CrossRef Anticoagulant Related Nephropathy Induced by Dabigatran
Nazia Sharfuddin, Mahra Nourbakhsh, Alan Box, Hallgrimur Benediktsson, Daniel A. Muruve
Case Reports in Nephrology.2018; 2018: 1. CrossRef Apixaban
Reactions Weekly.2018; 1686(1): 51. CrossRef
|